Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Invested Capital (2019 - 2025)

Marimed (MRMD) has disclosed Return on Invested Capital for 7 consecutive years, with 0.02% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 11.0% to 0.02% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.02%, a 11.0% decrease, with the full-year FY2024 number at 0.13%, down 39.0% from a year prior.
  • Return on Invested Capital was 0.02% for Q3 2025 at Marimed, up from 0.01% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.75% in Q1 2021 to a low of 0.03% in Q3 2023.
  • A 5-year average of 0.33% and a median of 0.19% in 2023 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: plummeted -4448bps in 2021, then increased 20bps in 2023.
  • Marimed's Return on Invested Capital stood at 0.24% in 2021, then increased by 4bps to 0.25% in 2022, then skyrocketed by 80bps to 0.45% in 2023, then crashed by -70bps to 0.13% in 2024, then tumbled by -84bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Return on Invested Capital are 0.02% (Q3 2025), 0.01% (Q2 2025), and 0.0% (Q1 2025).